MESA LABORATORIES INC /CO/ (MLAB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 90M 180M 270M FY17: 93.7M FY18: 96.2M FY19: 103.1M FY20: 117.7M FY21: 133.9M FY22: 184.3M FY23: 219.1M FY24: 216.2M FY25: 241M FY26: 249.1M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Gross Profit Annual

0 60M 120M 180M FY17: 53.2M FY18: 54.6M FY19: 60.9M FY20: 65.4M FY21: 87M FY22: 109.1M FY23: 133.7M FY24: 133.2M FY25: 150.9M FY26: 158.3M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Income Annual

-300M -200M -100M 0 100M 200M 300M FY17: 16.3M FY18: 2.2M FY19: 9.8M FY20: 7.9M FY21: 12.4M FY22: 4.7M FY23: 3.3M FY24: -272.1M FY25: 16.3M FY26: 18.5M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Net Income Annual

-270M -180M -90M 0 90M 180M 270M FY17: 11.2M FY18: -3M FY19: 7.5M FY20: 1.8M FY21: 3.3M FY22: 1.9M FY23: 930K FY24: -254.2M FY25: -2M FY26: 6.7M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Cost of Revenue Annual

0 35M 70M 105M FY17: 40.4M FY18: 41.6M FY19: 42.2M FY20: 52.3M FY21: 46.9M FY22: 75.2M FY23: 85.4M FY24: 82.9M FY25: 90.1M FY26: 90.9M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

0 20M 40M 60M FY17: 17.3M FY18: 25.7M FY19: 30.6M FY20: 27M FY21: 37.1M FY22: 39.2M FY23: 28M FY24: 44.1M FY25: 46.8M FY26: 42.8M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Free Cash Flow Annual

0 15M 30M 45M FY18: 22.9M FY19: 29.3M FY20: 25.5M FY21: 35.1M FY22: 34.8M FY23: 23.4M FY24: 41.6M FY25: 42.6M FY26: 39.6M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 2M 4M 6M FY17: 3.8M FY18: 3.8M FY19: 4M FY20: 4.4M FY21: 5.1M FY22: 5.3M FY23: 5.4M FY24: 5.4M FY25: 5.4M FY26: 5.6M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q4 '16: 2.97 Q1 '17: 2.74 Q2 '17: 2.88 Q3 '17: 3.03 Q4 '17: 2.91 Q1 '18: 2.79 Q2 '18: 2.77 Q3 '18: -1.00 Q4 '18: -0.86 Q1 '19: -0.19 Q2 '19: -0.54 Q3 '19: 2.60 Q4 '19: 1.86 Q1 '20: 1.93 Q2 '20: 2.41 Q3 '20: 1.17 Q4 '20: 0.46 Q1 '21: -0.41 Q2 '21: -0.63 Q3 '21: -0.49 Q4 '21: 0.62 Q1 '22: 0.74 Q2 '22: 0.93 Q3 '22: 1.43 Q4 '22: 0.35 Q1 '23: -0.30 Q2 '23: -0.76 Q3 '23: -0.29 Q4 '23: 0.17 Q1 '24: 0.34 Q2 '24: -0.13 Q3 '24: 0.18 Q4 '24: -47.20 Q1 '25: -46.48 Q2 '25: -45.62 Q3 '25: -46.32 Q4 '25: -0.36 Q1 '26: -0.13 Q2 '26: -0.31 Q3 '26: 0.65 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.